FDA Approves Lucentis Biosimilar Nufymco

• by mdspire news news staff

• January 2, 2026

Stuart Therapeutics Spotlights Topical RP Program

At OIS Retina, Eric Schlumpf discussed the company’s collagen mimetic peptide platform for retinitis pigmentosa, now in preclinical development.

• by Eric Schlumpf

• July 15, 2026

• 2 min

ASRS President Reflects on a Year of Change

As his term comes to a close, Geoffrey G. Emerson, MD, PhD, FASRS, discusses scientific advances, physician advocacy, and the collaborative leadership behind ASRS.

• by Geoffrey G. Emerson, MD, PhD, FASRS

• July 15, 2026

• 3 min

Can Oral Gildeuretinol Slow Advanced Macular Degeneration?

Although the trial missed its primary endpoint, exploratory analyses suggested slower lesion growth and better functional outcomes with gildeuretinol.

• by Andrea Surnit

• July 20, 2026

• 3 min